Allergy Relieving Eye Drops Market Global Forecast Report by Drug Class (Antihistamines, Non-steroidal anti-Inflammatory Drugs, Vasoconstrictors, Others), Type (Seasonal and Perennial Allergic Conjunctivitis, Vernal Keratoconjunctivitis, Atopic Keratoconjunctivitis, Giant Papillary Conjunctivitis, Others), Countries and Company Analysis 2024-2032
Buy NowAllergy Relieving Eye Drops Market Size
The Allergy Relieving Eye Drops market is expected to reach US$ 1.51 billion in 2023 to US$ 2.37 billion by 2032, with a CAGR of 5.15 % from 2024 to 2032. Some of the factors driving the market include the significant increase in demand for cost-effective and efficient allergy treatments, with a greater emphasis on non-invasive techniques, focused marketing and consumer education by major players, and ongoing technological advancements in the formulation and production of these products.
Global Allergy Relieving Eye Drops Industry Overview
Specialized pharmaceutical remedies called allergy-relieving eye drops are designed to reduce the symptoms of ocular allergies. Allergens including dust, pollen, and pet dander frequently cause these symptoms, which include discomfort, itching, redness, and swelling. By preventing the production of histamines, the antihistamines, lubricants, and other therapeutic ingredients that make up the eye drops prevent the body's allergic reaction. Agents that can calm mast cells and stop them from producing chemicals that trigger allergic reactions may be present in these eye drops. These eye drops improve comfort and eyesight by providing instant relief from allergy symptoms. Furthermore, they come in both prescription and over-the-counter drug formulations.
| Report Features | Details |
|
Base Year |
2023 |
|
Forecast Years |
2024 - 2032 |
|
Historical Years |
2019 - 2023 |
|
Market Size in 2023 |
US$ 1.51 Billion |
|
Market Forecast in 2032 |
US$ 2.37 Billion |
|
Market Growth Rate (2024-2032) |
5.14% |
In recent years, there has been an increase in eye allergies. The frequency of ocular allergies has been rising globally over the past few decades, per a PubMed study from October 2020. The International Study of Asthma and Allergies in Childhood (ISAAC) conducted a global survey that examined the geographic distribution and hot spots of rhino conjunctivitis. According to ISAAC, rhino conjunctivitis is significantly more common in Africa, Latin America, and Japan. Additionally, the World Bank Group's 2021 statistics shows that the proportion of people 65 and older (as a percentage of the total population) rose from 6.57 percent in 2020 to 6.78 percent in 2021; More eye issues will arise as the geriatric population grows, leading to a rise in the use of allergy-relieving eye drops. Therefore, it is anticipated to boost market expansion.
Growth Drivers for the Allergy Relieving Eye Drops Market
Awareness of Eye Health
The demand for allergy-relieving eye drops is mostly driven by rising public awareness of eye health. People are actively looking for efficient remedies as they learn more about how allergens affect eye comfort and vision. The significance of controlling allergy symptoms is highlighted by the expansion of information availability through digital media, medical campaigns, and educational programs. This knowledge supports preventive eye care procedures in addition to the use of specialty eye drops. The market for allergy-relieving eye drops is growing as consumers place a higher priority on their eye health, which increases demand for creative and practical solutions designed to reduce allergy-related discomfort.
Healthcare Professional Recommendations
Recommendations from medical professionals are essential in promoting allergy-relieving eye drops. Patients are more inclined to look for suitable treatments when eye care professionals stress the need of controlling allergy symptoms. Physicians and pharmacists inform patients about how allergens affect eye health and suggest particular eye drops that can help. This advice not only promotes proactive eye care among patients but also builds confidence in successful treatments. Additionally, the need for specialized allergy-relieving solutions rises as medical professionals emphasize the advantages of prompt intervention, propelling market expansion and enhancing patient outcomes in the management of ocular allergies.
Allergy Relieving Eye Drops Market Overview by Regions
Due to local healthcare dynamics, consumer behavior, and environmental factors that affect the prevalence of allergies, each region offers different opportunities and problems. An overview of the market by region is given below:
North America Allergy Relieving Eye Drops Market
United States
Due to the increasing frequency of allergic disorders and growing public awareness of eye health, the market for allergy-relieving eye drops in the US is thriving. Customers are actively looking for efficient alleviation options as seasonal allergies and allergic conjunctivitis become increasingly prevalent. Specialized eye drops are commonly recommended by medical specialists, increasing their prominence and legitimacy. Formulation innovations that address a range of customer needs include tailored delivery systems and preservative-free choices. These products are also more easily accessible thanks to the increase of e-commerce, which accelerates market expansion. In general, there is a high need for practical and efficient allergy treatment products in the US market.
An estimated 12 million Americans aged 40 and over have vision impairment, including 1 million who are blind, 3 million who have vision impairment following correction, and 8 million who have vision impairment as a result of uncorrected refractive error, according to data released by the CDC in June 2020. Therefore, during the forecast period, it is anticipated that the use of allergy-relieving eye drops will rise in tandem with the growing incidence of eye problems in the United States.
Europe Allergy Relieving Eye Drops Market
Germany
The market for allergy-relieving eye drops in Germany is expanding steadily due to an increase in allergy cases and heightened public awareness of eye health issues. Because hay fever and allergic conjunctivitis are so common, people are looking for efficient ways to get better. Specialized eye drops are recommended by healthcare specialists, which increases consumer adoption and trust. Innovative formulations, such as preservative-free goods that accommodate sensitive eyes, are highly valued in this market. Germany is positioned as a major player in the European allergy eye care industry as a result of the increased emphasis on wellness and preventive healthcare.
Asia Pacific Allergy Relieving Eye Drops Market
China
Due to rising urbanization, pollution, and the frequency of allergic disorders among the populace, China's market for allergy-relieving eye drops is growing quickly. The need for efficient relief products is rising as more people suffer from seasonal allergies and allergic conjunctivitis. Customers are seeking specialist treatments as a result of growing public knowledge of eye health. Innovative product offers, such as fast-acting and preservative-free formulations, are on the rise in the market. Furthermore, the availability of allergy eye drops is improved by the growing accessibility of healthcare and e-commerce platforms, which further drives market expansion in China.
Middle East & Africa Allergy Relieving Eye Drops Market
Saudi Arabia
The market for allergy-relieving eye drops in Saudi Arabia is expanding significantly due to rising allergy incidence and growing awareness of eye health issues. An increased prevalence of allergy disorders is caused by a number of factors, including lifestyle changes, environmental contaminants, and urbanization. The government's efforts to improve wellbeing and provide access to healthcare also help the industry grow. Specialized eye drops are recommended by healthcare specialists, which increases consumer trust in these items. In order to meet the varied demands and tastes of consumers in the area, the market is also distinguished by an increasing range of creative formulations, such as those without preservatives.
Allergy Relieving Eye Drops Company Analysis
The major participants in the Allergy Relieving Eye Drops market includes AbbVie Inc. (Allergan Plc), Johnson & Johnson, Pfizer Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Bausch Health Companies Inc, Regeneron Pharmaceuticals, Santen Pharmaceutical Co., etc.
Allergy Relieving Eye Drops Company News
In May 2022, Verkazia (cyclosporine ophthalmic emulsion) 0.1% has been made available in the US to treat vernal keratoconjunctivitis (VKC) eye allergy, according to a statement from Santen Inc., the US division of Santen Pharmaceutical Co., Ltd.
In March 2022, For the estimated 40% of Americans who suffer from ocular allergies, AbbVie Inc. (Allergan Plc) announced that LASTACAFT (alcaftadine ophthalmic solution 0.25%) is now available over-the-counter.
Drug Class - Industry is divided into 4 viewpoints:
- Antihistamines
- Non-steroidal anti-Inflammatory Drugs
- Vasoconstrictors
- Others
Type - Industry is divided into 5 viewpoints:
- Seasonal and Perennial Allergic Conjunctivitis
- Vernal Keratoconjunctivitis
- Atopic Keratoconjunctivitis
- Giant Papillary Conjunctivitis
- Others
Countries- Industry is divided into 25 viewpoints:
North America
- United States
- Canada
Europe
- France
- Germany
- Italy
- Spain
- United Kingdom
- Belgium
- Netherlands
- Turkey
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Thailand
- Malaysia
- Indonesia
- New Zealand
Latin America
- Brazil
- Mexico
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- United Arab Emirates
All companies have been covered with 5 Viewpoints
- Overview
- Key Persons
- Recent Development & Strategies
- Product Portfolio
- Financial Insights
Company Analysis
- AbbVie Inc. (Allergan Plc)
- Johnson & Johnson
- Pfizer Inc.
- F. Hoffmann-La Roche Ltd
- Novartis AG
- Bausch Health Companies Inc
- Regeneron Pharmaceuticals
- Santen Pharmaceutical Co
Report Details:
| Report Features | Details |
| Base Year |
2023 |
| Historical Period |
2019 - 2023 |
| Forecast Period |
2024 - 2032 |
| Market |
US$ Billion |
| Segment Covered |
Drug Class, Type, and Countries |
| Countries Covered |
|
| Companies Covered |
|
| Customization Scope |
20% Free Customization |
| Post-Sale Analyst Support |
1 Year (52 Weeks) |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request) |
Key Questions Answered in Report:
- How big is the Allergy Relieving Eye Drops industry?
- What is the Allergy Relieving Eye Drops growth rate?
- Who are the key players in Allergy Relieving Eye Drops industry?
- What are the factors driving the Allergy Relieving Eye Drops industry?
- Which Region held the largest market share in the Allergy Relieving Eye Drops industry?
- What segments are covered in the Allergy Relieving Eye Drops Market report?
Customization Services available
- Analysis of Market Size and Its Segments
- More Company Profiles (Upto 10 without any additional cost):
- Additional Countries (Other than mentioned Countries):
- Region/Country Specific Reports:
- Market Entry Strategy:
- Region-Specific Market Dynamics:
- Regional Market Share Analysis:
- Trade Analysis:
- Production Insights:
- Others Customized Requests:
For more information contact our analysts.
Need More Assistance?
- Talk to our analysts to get more precious information on the current market trends.
- Include more countries and segments and customize the report based on the final requirement.
- Get a competitive advantage in your industry by knowing the report findings and making a positive impact on your revenues and operations.
- Our analysts are always ready to provide more help and pertinent information if you need any additional assistance.
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Allergy Relieving Eye Drops Market
6. Market Share Analysis
6.1 Drug Class
6.2 Type
6.3 Country
7. Drug Class
7.1 Antihistamines
7.2 Non-steroidal anti-Inflammatory Drugs
7.3 Vasoconstrictors
7.4 Others
8. Type
8.1 Seasonal and Perennial Allergic Conjunctivitis
8.2 Vernal Keratoconjunctivitis
8.3 Atopic Keratoconjunctivitis
8.4 Giant Papillary Conjunctivitis
8.5 Others
9. Country
9.1 North America
9.1.1 United States
9.1.2 Canada
9.2 Europe
9.2.1 France
9.2.2 Germany
9.2.3 Italy
9.2.4 Spain
9.2.5 United Kingdom
9.2.6 Belgium
9.2.7 Netherlands
9.2.8 Turkey
9.3 Asia Pacific
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 Australia
9.3.5 South Korea
9.3.6 Thailand
9.3.7 Malaysia
9.3.8 Indonesia
9.3.9 New Zealand
9.4 Latin America
9.4.1 Brazil
9.4.2 Mexico
9.4.3 Argentina
9.5 Middle East & Africa
9.5.1 South Africa
9.5.2 Saudi Arabia
9.5.3 UAE
10. Porter’s Five Analysis
10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Rivalry
10.4 Threat of New Entrants
10.5 Threat of Substitutes
11. SWOT Analysis
11.1 Strength
11.2 Weakness
11.3 Opportunity
11.4 Threat
12. Company Analysis
12.1 AbbVie Inc. (Allergan Plc)
12.1.1 Overview
12.1.2 Key Persons
12.1.3 Recent Development & Strategies
12.1.4 Product Portfolio
12.1.5 Financial Insights
12.2 Johnson & Johnson
12.2.1 Overview
12.2.2 Key Persons
12.2.3 Recent Development & Strategies
12.2.4 Product Portfolio
12.2.5 Financial Insights
12.3 Pfizer Inc.
12.3.1 Overview
12.3.2 Key Persons
12.3.3 Recent Development & Strategies
12.3.4 Product Portfolio
12.3.5 Financial Insights
12.4 F. Hoffmann-La Roche Ltd
12.4.1 Overview
12.4.2 Key Persons
12.4.3 Recent Development & Strategies
12.4.4 Product Portfolio
12.4.5 Financial Insights
12.5 Novartis AG
12.5.1 Overview
12.5.2 Key Persons
12.5.3 Recent Development & Strategies
12.5.4 Product Portfolio
12.5.5 Financial Insights
12.6 Bausch Health Companies Inc
12.6.1 Overview
12.6.2 Key Persons
12.6.3 Recent Development & Strategies
12.6.4 Product Portfolio
12.6.5 Financial Insights
12.7 Regeneron Pharmaceuticals
12.7.1 Overview
12.7.2 Key Persons
12.7.3 Recent Development & Strategies
12.7.4 Product Portfolio
12.7.5 Financial Insights
12.8 Santen Pharmaceutical Co
12.8.1 Overview
12.8.2 Key Persons
12.8.3 Recent Development & Strategies
12.8.4 Product Portfolio
12.8.5 Financial Insights
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com